BackFrazier Lifesciences Acquisition - Units (1 Ord Share Class A & 1/3 War) Overview

Frazier Lifesciences Acquisition - Units (1 Ord Share Class A & 1/3 War) Total Liabilities

Frazier Lifesciences Acquisition - Units (1 Ord Share Class A & 1/3 War)'s total liabilities is $12M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$12.21M
47.68% YoYΔ $3.94M vs prior year quarter

Peer trimmed avg / median

Loading

Frazier Lifesciences Acquisition - Units (1 Ord Share Class A & 1/3 War) Total Liabilities History

Loading

Frazier Lifesciences Acquisition - Units (1 Ord Share Class A & 1/3 War) vs. peers: Total Liabilities Comparison

Loading

Frazier Lifesciences Acquisition - Units (1 Ord Share Class A & 1/3 War) Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Frazier Lifesciences Acquisition - Units (1 Ord Share Class A & 1/3 War) (FLACU) FAQ

Frazier Lifesciences Acquisition - Units (1 Ord Share Class A & 1/3 War)'s total liabilities stands at $12M as of September 2022. That compares with $8.3M in the prior-year period — up 47.7% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Frazier Lifesciences Acquisition - Units (1 Ord Share Class A & 1/3 War) reported $12M in total liabilities versus $8.3M a year earlier — a 47.7% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $8.3M in the prior-year period — up 47.7% year over year. Sustained growth in total liabilities can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Frazier Lifesciences Acquisition - Units (1 Ord Share Class A & 1/3 War)'s total liabilities evolved across reporting periods, while the comparison chart places FLACU next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.